Stocktoria

RxSight, Inc. RXST

Nasdaq · stock · Ophthalmic Goods · website · IPO 2021-07-30

RxSight, Inc. statistics & valuation

Market cap$221.9M
P / S1.6×
P / B0.8×
Net margin-29.0%
Return on equity-14.1%
FCF margin-14.4%
Return on capital-16.9%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
187.90% -215.50% -136.20% -54.60% -19.60% -29.00% 202020212022202320242025
Gross margin (%)
11.60% 20.00% 43.50% 60.40% 70.70% 76.60% 202020212022202320242025
Operating margin (%)
-241.30% -233.60% -129.20% -56.20% -26.30% -35.80% 202020212022202320242025
Return on equity (%)
-35.20% -74.30% -30.30% -9.80% -14.10% 202020212022202320242025
Shares outstanding
5.5M 27.4M 28.3M 36.1M 40.4M 41.2M 202020212022202320242025
Net debt ($)
$10.4M $15.4M $28.3M -$9.7M 202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
27.40% -25.30% -44.50% -26.60% -8.60% -12.50% 202020212022202320242025
Free cash flow margin (%)
-257.10% -206.50% -125.00% -52.10% -16.00% -14.40% 202020212022202320242025
Debt / equity (×)
0.29× 0.45× 0.00× 202020212022202320242025
EPS ($)
$0.15 -$3.57 -$2.41 -$1.41 -$0.71 -$0.95 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Gross margin76.6%70.7%60.4%43.5%20.0%11.6%
Operating margin-35.8%-26.3%-56.2%-129.2%-233.6%-241.3%
Net margin-29.0%-19.6%-54.6%-136.2%-215.5%187.9%
FCF margin-14.4%-16.0%-52.1%-125.0%-206.5%-257.1%
Return on assets-12.5%-8.6%-26.6%-44.5%-25.3%27.4%
Return on equity-14.1%-9.8%-30.3%-74.3%-35.2%-6.4%
Debt / equity——0.00×0.45×0.29×-0.06×
Current ratio10.9511.368.067.8115.927.03

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.